We are live on ! Find out more
HS

HighVista Strategies Portfolio holdings

AUM $362M
1-Year Est. Return 230.96%
This Fund
S&P 500
This Quarter Est. Return
+18.87%
1 Year Est. Return
+230.96%
3 Year Est. Return
+518.4%
5 Year Est. Return
+644.94%
10 Year Est. Return
+2,223.31%
AUM
$137M
AUM Growth
+$16.5M
Cap. Flow
+$772K
Cap. Flow %
0.56%
Top 10 Hldgs %
68.51%
Holding
147
New
47
Increased
29
Reduced
15
Closed
34

Top Buys

Rank Stock Value
1
DLPH
Delphi Technologies PLC Ordinary Shares
DLPH
+$3.12M
2
LVGO
Livongo Health, Inc. Common Stock
LVGO
+$3.04M
3
MXIM
Maxim Integrated Products
MXIM
+$2.88M
4
GRUB
Just Eat Takeaway.com N.V. American Depositary Shares
GRUB
+$2.01M
5
STRO icon
Sutro Biopharma
STRO
+$611K

Top Sells

Rank Stock Value
1
TECD
Tech Data Corp
TECD
+$7.91M
2
CZR
Caesars Entertainment Corporation
CZR
+$4.15M
3
LOGM
LogMein, Inc.
LOGM
+$2.89M
4
PRNB
Principia Biopharma Inc. Common Stock
PRNB
+$548K
5
EIDX
Eidos Therapeutics, Inc. Common Stock
EIDX
+$505K

Sector Composition

Rank Sector Weight
1 Technology 36.76%
2 Healthcare 21.07%
3 Financials 13.05%
4 Consumer Discretionary 10.17%
5 Communication Services 3.33%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
RNAM
51
DELISTED
Avidity Biosciences
RNAM
$484K 0.35%
+17,202
New +$497K
CRNX icon
52
Crinetics Pharmaceuticals
CRNX
$8.95B
$483K 0.35%
30,845
+5,144
+20% +$78.6K
GERN icon
53
Geron
GERN
$1.05B
$482K 0.35%
+277,080
New +$513K
XENE icon
54
Xenon Pharmaceuticals
XENE
$6.11B
$482K 0.35%
43,517
+23,278
+115% +$274K
RLMD icon
55
Relmada Therapeutics
RLMD
$477M
$473K 0.34%
12,565
+2,872
+30% +$111K
NGNE icon
56
Neurogene
NGNE
$714M
$471K 0.34%
1,962
+534
+37% +$129K
FOLD
57
DELISTED
Amicus Therapeutics
FOLD
$464K 0.34%
32,893
+6,030
+22% +$87.9K
MGNX icon
58
MacroGenics
MGNX
$249M
$457K 0.33%
+18,144
New +$495K
DRNA
59
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
$448K 0.33%
24,920
+3,719
+18% +$77K
PRTA icon
60
Prothena Corp
PRTA
$473M
$444K 0.32%
+44,414
New +$534K
ADAP
61
DELISTED
Adaptimmune Therapeutics
ADAP
$443K 0.32%
+55,479
New +$486K
ASMB icon
62
Assembly Biosciences
ASMB
$540M
$439K 0.32%
+2,224
New +$560K
AXSM icon
63
Axsome Therapeutics
AXSM
$11.1B
$428K 0.31%
6,012
-929
-13% -$72.4K
GBT
64
DELISTED
Global Blood Therapeutics, Inc.
GBT
$416K 0.3%
7,549
+1,288
+21% +$81.9K
CNST
65
DELISTED
Constellation Pharmaceuticals, Inc.
CNST
$398K 0.29%
19,664
+4,776
+32% +$117K
RCKT icon
66
Rocket Pharmaceuticals
RCKT
$382M
$396K 0.29%
17,342
-7,682
-31% -$189K
ADVM
67
DELISTED
Adverum Biotechnologies
ADVM
$369K 0.27%
3,580
+960
+37% +$144K
ZGNX
68
DELISTED
Zogenix, Inc.
ZGNX
$349K 0.25%
19,492
+4,275
+28% +$105K
AVDL
69
DELISTED
Avadel Pharmaceuticals
AVDL
$290K 0.21%
57,495
+6,087
+12% +$44.3K
CHKP icon
70
Check Point Software Technologies
CHKP
$13.2B
$241K 0.18%
2,000
-800
-29% -$97.6K
SRNE
71
DELISTED
Sorrento Therapeutics, Inc.
SRNE
$201K 0.15%
+18,000
New +$165K
QNST icon
72
QuinStreet
QNST
$1.2B
$196K 0.14%
12,400
– –
UBS icon
73
UBS Group
UBS
$176B
$155K 0.11%
+15,080
New +$181K
TRUE
74
DELISTED
TrueCar
TRUE
$149K 0.11%
+29,700
New +$125K
VRA icon
75
Vera Bradley
VRA
$95M
$141K 0.1%
+23,100
New +$123K
1 2
3
4 5

Similar funds

SIAG
Safeguard Investment Advisory Group Corona, California $362M AUM 20.96% 1-Year Est. Return
MS
Millington Securities Red Bank, New Jersey $362M AUM
WTFG
Wood Tarver Financial Group Boise, Idaho $362M AUM 14.75% 1-Year Est. Return
A6
Anchor @ 65 Singapore $362M AUM 20.02% 1-Year Est. Return
PI
Pennant Investors Summit, New Jersey $361M AUM 134.26% 1-Year Est. Return
ACM
Anfield Capital Management Irvine, California $363M AUM 24.08% 1-Year Est. Return
PPG
Peak Planning Group Centennial, Colorado $361M AUM 22.01% 1-Year Est. Return
PWC
PYA Waltman Capital Knoxville, Tennessee $361M AUM 9.49% 1-Year Est. Return

HighVista Strategies's Q3 2020 Portfolio in Review

As of Q3 2020, HighVista Strategies held 147 positions worth $137M, up 14% from $121M the previous quarter. Its ten largest holdings account for 69% of the portfolio.

HighVista Strategies's Q3 2020 filing shows 47 new, 29 increased, 15 reduced and 34 closed positions. Its largest new stake was Delphi Technologies PLC Ordinary Shares: 189,132 shares worth $3.16M. The largest sale was Tech Data Corp, an estimated $7.91M.

By sector, the portfolio is most concentrated in Technology at 37% of assets, down from 43% a quarter earlier, followed by Healthcare and Financials.

  • HighVista Strategies's largest Q3 2020 buy was Delphi Technologies PLC Ordinary Shares: 189,132 shares worth $3.16M.
  • HighVista Strategies added most to Xenon Pharmaceuticals in Q3 2020, an estimated $274K increase.
  • HighVista Strategies's biggest Q3 2020 reduction was Kadmon Holdings, Inc., cutting an estimated $256K.
  • HighVista Strategies fully exited Tech Data Corp in Q3 2020, selling an estimated $7.91M.
  • HighVista Strategies's ten largest holdings make up 69% of its $137M portfolio in Q3 2020.
  • HighVista Strategies opened 47 new positions and closed 34 in Q3 2020.
  • HighVista Strategies's portfolio value rose 14% quarter-over-quarter to $137M.

Based on HighVista Strategies's 13F filing for Q3 2020, filed 16 Nov 2020.